Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters

Database
Language
Journal subject
Affiliation country
Publication year range
1.
Biomarkers ; 24(5): 492-498, 2019 Jul.
Article in English | MEDLINE | ID: mdl-31099265

ABSTRACT

Objective: The aim of the present work is to evaluate the toxicity of titanium dioxide nanoparticles (TiO2NPs) according to their doses and particle sizes. Materials and methods: The effect of five days oral administration of TiO2NPs (21 and 80 nm) with different doses (50, 250 and 500 mg/kg body weight) was assessed in mice via measurement of oxidative stress markers; glutathione (GSH), superoxide dismutase (SOD), catalase (CAT), malondialdehyde (MDA) and nitric oxide (NO), liver function indices; aspartate and alanine aminotransferases (AST and ALT), chromosomal aberrations and liver histopathological pattern. Results: The results revealed drastic alterations in all the measured parameters and showed positive correlation with the gradual dose increment. In addition, the smaller particle size of TiO2NPS (21 nm) had more adverse effect in all the selected biochemical parameters, genetic aberrations and histological investigations. Conclusions: Toxicity of TiO2NPs increases in a dose-dependent manner and vice versa with particles size. The evaluated biomarkers are good indicators for TiO2NPs toxicity. More detailed studies are required before the recommendation of TiO2NPS as food additives.


Subject(s)
Biomarkers/blood , Nanoparticles/toxicity , Titanium/toxicity , Alanine Transaminase/blood , Animals , Aspartate Aminotransferases/blood , Catalase/blood , Chromosome Aberrations/drug effects , Dose-Response Relationship, Drug , Glutathione/blood , Liver/metabolism , Liver/pathology , Malondialdehyde/blood , Mice , Nanoparticles/metabolism , Nitric Oxide/metabolism , Oxidative Stress/drug effects , Particle Size , Superoxide Dismutase/blood , Titanium/metabolism
2.
Mutat Res ; 516(1-2): 1-9, 2002 Apr 26.
Article in English | MEDLINE | ID: mdl-11943604

ABSTRACT

The protective effect of calcium given orally by gavage with two doses (40 and 80mg/kg body weight) was evaluated against clastogenecity induced by lead acetate with two concentrations (200 and 400mg/kg diet) on bone marrow and spermatocyte cells of mice in vivo. The parameter screened was percentage of chromosomal aberrations with and without gaps and sperm abnormalities. Statistical analyses indicated the protection efficacy of calcium with the high dose rather than the other in both types of mouse cells. The observation from the laboratory tests, dealing that lead acetate can be considered as an environmental genotoxic material. We recommended that it must be administered of calcium (as calcium chloride) as a protective agent to reduce the genotoxic effect of lead in the somatic and germ cells.


Subject(s)
Bone Marrow/drug effects , Calcium/therapeutic use , Chromosome Aberrations/drug effects , Lead/toxicity , Spermatocytes/drug effects , Animals , Chromosomes/drug effects , Male , Meiosis/drug effects , Mice , Mutagenicity Tests , Organometallic Compounds , Spermatocytes/pathology
3.
Mutat Res ; 516(1-2): 11-7, 2002 Apr 26.
Article in English | MEDLINE | ID: mdl-11943605

ABSTRACT

The protective effect of Nigella sativa seed extract and its main constituents thymoquinone (TQ) was studied on mouse cells infected with schistosomiasis. Bone marrow cells in the in vivo experiments and spleen cells in the in vitro one were used to evaluate the potentially protective effect of these natural compounds on the induction of chromosomal aberrations. Karyotyping of the mice cells illustrated that the main abnormalities were gaps, fragments and deletions especially in chromosomes 2, 6 and some in chromosomes 13 and 14. Both N. sativa extract and TQ were considered as protective agents against the chromosomal aberrations induced as a result of schistosomiasis.


Subject(s)
Benzoquinones/pharmacology , Bone Marrow Cells/parasitology , Plant Extracts/pharmacology , Plant Oils/metabolism , Schistosomiasis/drug therapy , Spleen/parasitology , Animals , Antineoplastic Agents/pharmacology , Bone Marrow Cells/cytology , Bone Marrow Cells/drug effects , Chromosome Aberrations/drug effects , Chromosomes/drug effects , Karyotyping , Male , Mice , Schistosomiasis/transmission , Seeds/chemistry , Spleen/cytology , Spleen/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL